In this Opinion article, the authors propose that the immunological process that underlies type 1 diabetes is relapsing–remitting in nature; they highlight the supporting evidence and the remaining controversies, and discuss the possible therapeutic implications of their hypothesis.
- Matthias von Herrath
- Srinath Sanda
- Kevan Herold